Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry
- 25 May 2005
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 819 (2), 259-276
- https://doi.org/10.1016/j.jchromb.2005.02.010
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Simultaneous determination of the antiretroviral agents: amprenavir, lopinavir, ritonavir, saquinavir and efavirenz in human peripheral blood mononuclear cells by high-performance liquid chromatography–mass spectrometryJournal of Chromatography B, 2004
- Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometryJournal of Chromatography B, 2004
- Sensitive Enzyme Immunoassay for Measuring Plasma and Intracellular Nevirapine Levels in Human Immunodeficiency Virus-Infected PatientsAntimicrobial Agents and Chemotherapy, 2004
- Therapeutic Drug MonitoringDrugs, 2003
- Intracellular Concentration of Protease Inhibitors in HIV-1--Infected Patients: Correlation with MDR-1 Gene Expression and Low Dose of RitonavirHIV Research & Clinical Practice, 2002
- PharmAdaptAIDS, 2002
- Intracellular Accumulation of Human Immunodeficiency Virus Protease InhibitorsAntimicrobial Agents and Chemotherapy, 2002
- Improved method for the simultaneous determination of d4T, 3TC and ddl intracellular phosphorylated anabolites in human peripheral‐blood mononuclear cells using high‐performance liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2002
- Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2001
- Phenotypic Changes in Drug Susceptibility Associated with Failure of Human Immunodeficiency Virus Type 1 (HIV‐1) Triple Combination TherapyThe Journal of Infectious Diseases, 1999